Financials

  • Market Capitalization 1.27 B
  • Employee 592
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
283.5
Price to sales ratio
5.25

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2267
MGTX
MeiraGTx Holdings plc - Ordinary Shares
14.14 USD-2.88%-1.60%+20.85%+61.60%1.36 B USD
2302
MLTX
MoonLake Immunotherapeutics - Class A Ordinary Shares
15.15 USD-2.45%-3.75%-18.50%+58.47%1.29 B USD
2313
DRTS
Alpha Tau Medical Ltd. - Ordinary Shares
14.52 USD-1.96%-1.56%+24.74%+341.34%1.28 B USD
2318
IMTX
Immatics N.V. - Ordinary Shares
9.61 USD+2.67%+7.37%+10.71%-7.15%1.29 B USD

Frequently asked questions about Mannkind Corporation

What is the Mannkind Corporation stock price today?

The current price of Mannkind Corporation (MNKD) is 3.95. Over the past 24 hours, the stock has changed by -2.71%. Follow the MNKD chart for real-time price dynamics.

What is the stock ticker of Mannkind Corporation?

Mannkind Corporation trades under the ticker MNKD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Mannkind Corporation stock going up?

MNKD has changed by -8.35% over the last week, +1.28% over the last month, and -25.47% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Mannkind Corporation?

Mannkind Corporation currently has a market capitalization of 1.27 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Mannkind Corporation earnings last quarter?

Last quarter, Mannkind Corporation reported earnings of -0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Mannkind Corporation revenue for the last quarter?

Mannkind Corporation reported quarterly revenue of 107.01 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Mannkind Corporation net income for the last quarter?

Mannkind Corporation reported net income of -19.03 M for the last quarter. The previous quarter showed -16.62 M, which means net income changed by -14.52%.

How many employees does Mannkind Corporation have?

As of the latest available data, Mannkind Corporation has 592 employees. Workforce size can provide additional context about the company's scale and operations.

What is Mannkind Corporation EBITDA?

Mannkind Corporation EBITDA is 4.1 M, and its EBITDA margin is 3.83%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Mannkind Corporation stock?

You can buy Mannkind Corporation (MNKD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Mannkind Corporation stock?

Investing in Mannkind Corporation requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MNKD chart and related analysis on metatrader.com as part of your research.

MannKind Corporation - Common Stock

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

News